Home  /  Resource Library  /  Subgroup Analyses of Elderly Patients Aged > 70 Years in MAGNIFY: A Phase IIIb Interim Analysis of Induction R2 Followed By Maintenance in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

Subgroup Analyses of Elderly Patients Aged > 70 Years in MAGNIFY: A Phase IIIb Interim Analysis of Induction R2 Followed By Maintenance in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

ASH 2020: Subanalysis of a phase III trial investigating lenalidomide combined with rituximab for treatment of elderly patients with relapsed indolent lymphomas.